With only 200 mill shares on issue this is why RAC can and will...

With only 200 mill shares on issue this is why RAC can and will achieve a great result in a high SP.
now it's pretty simple for every $1 billion AU the SP goes up $5
Now forget 3 to 5 times peak sales for now and just add what you think bisantrene is worth to pharm or what you think they will pay to have it.
$7 billion = $35 a share
$10 billion = $50 a share
$15 billion = $75 a share
$20 billion = $100 a share
You can see how the SP can get to extremely a high price.
All you have to determine for yourselves what do you think it's worth to big pharma and what you think they will pay to have it,
the calculations are pretty simple to do once you have determined what you think pharm will pay.